BCTX
Briacell Therapeutics
BCTX
BCTX
15 hedge funds and large institutions have $181K invested in Briacell Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$11.3K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$6.51K |
| 3 |
Morgan Stanley
New York
|
-$2.2K |
| 4 |
CWP
Concord Wealth Partners
Abingdon,
Virginia
|
-$1.22K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$638 |
